Právní předpis byl sestaven k datu 25.10.2018.
Zobrazené znění právního předpisu je účinné od 25.10.2018 do 02.06.2021.
Příloha č. 1 - Seznam č. 1 omamných látek
Příloha č. 2 - Seznam č. 2 omamných látek
Příloha č. 3 - Seznam č. 3 omamných látek
Příloha č. 4 - Seznam č. 4 psychotropních látek
Příloha č. 5 - Seznam č. 5 psychotropních látek
Příloha č. 6 - Seznam č. 6 psychotropních látek
Příloha č. 7 - Seznam č. 7 psychotropních látek
Příloha č. 8 - Seznam č. 8 vybraných přípravků
č. 46/2017 Sb. - Čl. II
č. 30/2018 Sb. - Čl. II
č. 242/2018 Sb. - Čl. II
463
NAŘÍZENÍ XXXXX
xx xxx 18. prosince 2013
x xxxxxxxxx xxxxxxxxxx xxxxx
Xxxxx xxxxxxxx podle §44c xxxx. 1 zákona x. 167/1998 Sb., x xxxxxxxxxx látkách x x změně xxxxxxxxx xxxxxxx zákonů, xx znění xxxxxx x. 273/2013 Xx.:
§1
Xxxx nařízení stanoví
a) x příloze č. 1 x xxxxxx nařízení seznam
1. xxxxxxxx látek zařazených xx Xxxxxxx I xxxxx Jednotné xxxxxx x xxxxxxxx xxxxxxx1) x
2. xxxxxxx omamných xxxxx, s nimiž xx x xxxxxx xxxxxxx xxxxxx zneužívání xxxxx proto, že xxxxxxxxxxxxx xxxx nepřímo xxxxxxxx xxxxxx, xxxxxxxx xxxxxxx xxxxxxxxx jen xx základě xxxxxxxx x xxxxxxxxx, nebo xx z tohoto xxxxxx xxxxx xxxxxxxxxx, xxx xxxxxx xxxxxxxxx xxxxxxxxxx tyto xxxxxx xxxxx xxxx xxxxxxxx x xxxxxxx pouze xx xxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx xxxxxx směřujícím x xxxxxx xxxxxxx rohu xx xxxxxxx horního xxxx,
(xxxx jen "seznam x. 1 xxxxxxxx xxxxx"),
x) v příloze č. 2 x xxxxxx xxxxxxxx xxxxxx
1. omamných látek xxxxxxxxxx xx Seznamu XX xxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx a
2. xxxxxxx xxxxxxxx látek, x xxxxx xx x xxxxxx rozsahu xxxxxx xxxxxxxxxx xxxxx proto, xx xxxxxxxxxxxxx xxxx xxxxxxx ohrožují xxxxxx, xxxxx xxxxxxxxxx, xxx xxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxx látky xxxx xxxxxxxx x xxxxxxx na xxxxxx xxxx žádanku bez xxxxxxxx xxxxxx pruhem,
(dále xxx "xxxxxx x. 2 xxxxxxxx xxxxx"),
x) x příloze č. 3 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxx látek xxxxxxxxxx xx Xxxxxxx XX xxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx x
2. xxxxxxx xxxxxxxx xxxxx, x xxxxx xx x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx nepřímo xxxxxxxx xxxxxx, nutné xxxxxxxxxx, xxx xxxxx x xxxxxxxxx xxxxxxxxxx xxxx xxxxxx xxxxx xxxx xxxxxxxxx pouze x xxxxxxxx výzkumným, xxxxxxxx x xxxxx xxxxxxxx xxxxxxxxxxxxx účelům xxxxxxxxx x xxxxxxxx x xxxxxxxxx,
(xxxx xxx "xxxxxx x. 3 xxxxxxxx xxxxx"),
x) v příloze č. 4 k tomuto xxxxxxxx xxxxxx
1. xxxxxxxxxxxxxx xxxxx zařazených xx Xxxxxxx X podle Xxxxxx x psychotropních xxxxxxx2) a
2. xxxxxxx xxxxxxxxxxxxxx látek, u xxxxx xx z xxxxxx rozsahu xxxxxx xxxxxxxxxx anebo xxxxx, xx xxxxxxxxxxxxx nebo xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, aby xxxxx x xxxxxxxxx xxxxxxxxxx tyto psychotropní xxxxx xxxx xxxxxxxxx xxxxx x xxxxxxxx xxxxxxxxx, vědeckým x xxxxx omezeným xxxxxxxxxxxxx xxxxxx xxxxxxxxx x xxxxxxxx x xxxxxxxxx,
(xxxx xxx "xxxxxx č. 4 psychotropních xxxxx"),
x) x příloze č. 5 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XX xxxxx Xxxxxx o xxxxxxxxxxxxxx xxxxxxx a
2. xxxxxxx xxxxxxxxxxxxxx látek, x xxxxx xx x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx ohrožují xxxxxx, nezbytné xxxxxxx xxxxxxxxx xxx xx xxxxxxx xxxxxxxx k xxxxxxxxx, xxxx xx x xxxxxx důvodu xxxxx xxxxxxxxxx, xxx xxxxxx přípravky xxxxxxxxxx xxxx psychotropní xxxxx xxxx xxxxxxxx v xxxxxxx pouze xx xxxxxx xxxx xxxxxxx xxxxxxxx modrým pruhem xxxxxxxxxx x xxxxxx xxxxxxx rohu xx xxxxxxx horního rohu,
(dále xxx "seznam x. 5 xxxxxxxxxxxxxx látek"),
f) x příloze č. 6 x xxxxxx nařízení seznam xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XXX xxxxx Úmluvy x xxxxxxxxxxxxxx látkách,
x) x příloze č. 7 x tomuto xxxxxxxx seznam
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx do Xxxxxxx XX podle Xxxxxx x xxxxxxxxxxxxxx xxxxxxx x
2. xxxxxxx xxxxxxxxxxxxxx látek, x xxxxx xx x xxxxxx rozsahu jejich xxxxxxxxxx xxxxx proto, xx xxxxxxxxxxxxx xxxx xxxxxxx ohrožují xxxxxx, xxxxx xxxxxxxxxx, aby xxxxxx xxxxxxxxx obsahující xxxx xxxxx byly xxxxxxxx x xxxxxxx xx recept xxxx xxxxxxx xxx označení xxxxxx pruhem,
(dále jen "xxxxxx x. 7 xxxxxxxxxxxxxx látek"), x
x) x příloze č. 8 x xxxxxx xxxxxxxx seznam xxxxxxxxx zařazených xx Xxxxxxx XXX podle Xxxxxxxx xxxxxx x xxxxxxxx látkách,
(dále xxx "xxxxxx x. 8 xxxxxxxxx xxxxxxxxx").
§2
(1) Xxxx nařízení xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx 98/34/ES xx xxx 22. xxxxxx 1998 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x oblasti xxxxx x technických xxxxxxxx x předpisů xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx, x xxxxxxx znění.
(2) Xxxx xxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx Evropské xxxx xxxxxxxx xx xxxxxxxxxx látek3).
§3
Xxxx xxxxxxxx xxxxxx xxxxxxxxx xxxx 1. xxxxx 2014.
Příloha č. 1 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 1 omamných xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx (XXX) x českém xxxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(5X,6X,7X)-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-4,5-xxxxx- 6,14-ethenomofinan-3-yl-acetán |
|
|
AcelyI-alfa-methylfentanyl |
(RS)-N-[1-(2-fenyI-2-methylethyl)-4-piperidyl]acetanilid |
|
|
AcetyImethadol |
(3RS)-6-(dirnethylamino)-4,4-difenylheptan-3-yl-acetát |
|
|
Alfacetylmethadol |
(3R,6R)-6-(dimethylamino)-4,4-difenylheptan-3-yl-acetát |
|
|
Alfameprodin |
(3RS,4Rs)-3-elhyl-4-fenyl-1-methylpiperidin-4-yl-propanoát |
|
|
Alfarnethadol |
(3R,6R)-6-(dimethylamino)-4,4-difenylheptan-3-ol |
|
|
Alfa-methylfentanyl |
N-{1-[(1RS)-2-fenyl-1-methylethyl]piperidin-4-yl}propananilid |
|
|
Alfa-methylthiofentanyl |
N-{1-[(1RS)-1-methyl-2-(2-thienyl)ethyl]piperidin-4-yl}propananilid |
|
|
AIfaprodin |
(3R,4SR)-4-fenyl-1,3-dimethylpiperidin-4-yI-propanoát |
|
|
Alfentanil |
N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl) xxxxxxxxx-4-xx}-X-xxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxx |
3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-1-(4-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxx |
xxxxx-1-[2-(xxxxxxxxx)xxxxx]-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
3-(xxxxxxXxxx)-4.5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
(3X,6X)-6-{xxxxxxxxxxxxx )-4.4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]-3-xxxxxxxxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX,4XX)-3-xxxxx-4-xxxxX-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(3XX,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
2,2-xxxxxxX-4-[4-(2-xxx-3-xxxxxxxxX-2,3-xxxxxxx-1X-xxxxxxxxxxxx-1-xx) piperidino]butannitril |
|
|
Dextromoramid |
1-[(3S)-2,2-difenyl-3-methyl-4-morfolinobutanoyl]pyrrolidin |
|
|
Diampromid |
N-[2-(N-fenethyl-N-methylamono)propyl]propananilid |
|
|
Diethyltriambuten |
3-(diethylamino)-1,1-di(2-thienyl)but-1-en |
|
|
Difenoxin |
1-(3,3-difenyl-3-kyanpropyl-4-fenylpiperidin-4-karhoxylová kyselina |
|
|
Difenoxylát |
ethyl-1-(3,3-difenyl-3-kyanpropyl)-4-fenylpiperidin-4-karboxylát |
|
|
Dihydroetorfin |
(5R,6R,7R)-4,5-epoxy-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl- 6,14-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α-xxxx |
|
|
Xxxxxxxxxxx |
[2-(xxxxxxxxxxxxx)xxxxx)]-2-xxxxxx-2,2-xxxxxxx-xxxxxx |
|
|
Xxxxxxxxxxxx |
6-(xxxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
X,X,1-xxxxxxxxx-3,3-xx(2-xxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxx-xxxxxxx |
xxxxx-2,2-xxxxxxx-4-xxxxxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
|
Xxxxxxxxx |
(6XX)-4,4-xxxxxxx-6-xxxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(6X)-3,4-xxxxxxxxx-17-xxxxxxxxxxxxxx-6β,14-xxxx |
|
|
Xxxxxxx |
xxxxxxxx (1R,2R,3S,5S)-3-hydroxy-8-methyl-9-azabicyklo[3.2.1]oktan-2-karboxylová, xxxx xxxxxx a xxxxxxxx, x xxxxxxx xx xxxxx xxxxxx ekgonin x xxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
X-xxxxx-X,1-xxxxxxxx-3,3-xxx(2-xxxxxxx)-2-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
1-[2-(xxxxxxxxxxxx)xxxxx]-2-(4-xxxxxxxxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-[2-(2-xxxxxxxxxxxxx)xxxxx]xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
X-(1-xxxxxx-2-xxxxxxxxxxxxxxx)xxxxxxxxxxxx |
|
|
Xxxxxxxxx |
(2XX,6X,11X)-3-xxxxxxxx-6,11-xxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxx- 3-benzazocin-8-ol |
|
|
Fenomorfan |
17-fenethyImorfinan-3-ol |
|
|
Fenoperidin |
ethyl-4-fenyl-1-(3-fenylpropyl)-3-hydroxypiperidin-4-karboxylát |
|
|
Fentanyl |
N-(1-fenethylpiperidin-4-yl)-N-fenylpropanamid |
|
|
Furethidin |
ethyI-4-fenyI-1-[2-(furfuryloxy)ethyl]piperidinn-4-karboxylát |
|
|
Hydrokodon |
4,5α-epoxy-3-methoxy-17-rnethyImorfinan-6-on |
|
|
Hydromorfinol |
4,5α-epoxy-17-methylmorfinan-3,6α,14-triol |
|
|
Hydromorfon |
4,5α-epoxy-3-hydroxy-17-rnethylmorfinan-6-on |
|
|
Hydroxypethidin |
ethyl-4-(3-hydroxyfenyl)-1-rnethylpiperidin-4-karboxylát |
|
|
lsomethadon |
6-(dimethylamino)-4,4-difenyl-5-methylhexan-3-on |
|
|
Karfentanil |
methyl-1-fenethyl-4-(N-fenylpropanamido)piperidin-4-karboxylát |
|
|
Klonitazen |
2-(4-chlorbenzyl)-1-[2-(diethylarnino)ethyl]-5-nitro-1H-benzimidazol |
|
|
Kodoxim |
kyselina 2-{[X-(4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxxx-6-xxxxxx) amino]oxy}octová |
|
|
Koka - xxxx |
Xxxxxx xxxx |
|
|
Xxxxxx |
(1X,2X,3X,5X)-3-(xxxxxxxxxx)-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2- xxxxxxxxxx |
|
|
Xxxxxxxxxx x xxxxxxxx |
Xxxxxxxxxxx x xxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx xxxxxxxx |
|
|
Xxxxxx xxxxxxx a xxxxxxxx |
Xxxxxxx x xxxxxxxx x xxxxxx |
|
|
Xxxxxx pro xxxxxxx xxxxxxx |
xxxxxx určené x xxxxxxxx léčivých xxxxxxxxx xx standardizovaným xxxxxxx xxxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
1-xxxxx-2-[(9X,13X,14X)3-xxxxxxxxxxxxxxx-17-xx]xxxxx-1-xx |
|
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-3-xxxxxxxx-17-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxx dextromethorfan [(+)-3-xxxxxxx-17- xxxxxxxxxxxxxx] xx xxxxx xx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx v xxxx xxxxxxx |
|
Xxxxxxxxxxx |
(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
Xxxxxxxxxx |
(9X,13X,14X)-17-xxxxxxxxxxxxxx-3-xx |
Xxxxxxxxxxxxxx dextrofanol [(+)-3-xxxxxxx-17- methylmorfinan] xx xxxxx xx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx x xxxx xxxxxxx |
|
Xxxxxxxxx |
(2X,6X,11X)-3,6,11-xxxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxxxx-3- xxxxxxxxx-8-xx |
|
|
Xxxxxxxx |
(6XX)-6-(xxxxxxxxxxxxx)4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxx, meziprodukt |
4-(dimethylamono)-2,2-difenylpentanitril |
|
|
Methyldesorfin |
4,5α-epoxy-6,17-dimethylmorfin-6-en-3-ol |
|
|
Methyldihydromorfin |
4,5-epoxy-6,17-dimethylmorfinan-3,6-diol |
|
|
Metopon |
4,5-epoxy-3-hydroxy-5,17-dimethylmorfinan-6-on |
|
|
Moramid, meziprodukt |
2,2-difenyl-3-methyl-4-rnorfolinobutanová xxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
X-(1-xxxxxxxx-3-xxxxxxxxxxxxxxx-4-xx)xxxxxxxxxxxx |
3-Xxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxx |
X-{(3XX)-3-xxxxxx-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
3-xxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxx |
4,5α-xxxxx-17-xxxxxXxxxxxx-7-xx-3,6α-xxxx |
|
|
Xxxxxx xxxxxxxxxxx |
4,5α-xxxxx-3,6α-xxxxxxxxx-17,17-xxxxxxxxxxxxxx-7-xx-17-xxx-xxxxxx |
x xxxx xxxxxxxx xxxxxxx se xxxxxxxxxx dusíkem včetně xxxxxxxx xxxxxx-X-xxxxx (x xxxxxx-X-xxxxx) |
|
Xxxxxx-X-xxxx |
4,5α -epoxy-17-methylmorfin-7-en-3,6α-diol-17-oxid |
|
|
DesmethyIprodin |
4-fenyl-1-methylpiperidin-4-yl-propanoát |
MPPP |
|
Myrofin |
3-(benzyloxy)-4,5α-epoxy-17-methylmorfin-7-en-6-yl-tetradekanoát |
|
|
Nikomorfin |
4,5α-epoxy-17-methylmorfin-7-en-3,6α-diyl-dinikotinát |
|
|
Noracymethadol |
4,4-difenyl-6-(methylamono)heptan-3-yl-acetát |
|
|
Norlevorfanol |
(9R,13R,14R)-morfinan-3-ol |
|
|
Normethadon |
6-(dimethylamono)-4,4-difenylhexan-3-on |
|
|
Normorfin |
4,5α-epoxymorfin-7-en-3,6α-dioI |
|
|
Norpipanon |
4,4-defenyl-6-piperidinohexan-3-on |
|
|
Opium |
Kromě homeopaticky xxxxxxxxxx xxxxxxxx, xxxxxxx xxxxxx xxxxxx je xxxxx xxx D4 xxxx XX2 |
|
|
Xxxxxxxx |
4,5α-xxxxx-6-xxxxxxx-17-xxxxxxxxxxxxx-6,8(14)-xxxx-3-xx |
|
|
Xxxxxxxx |
(5X)-4,5-xxxxx-14-xxxxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxx |
(5X)-4,5-xxxxx-3,14-xxxxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxxxxxx |
X-(1-xxxxxxxXxxxxxxxxx-4-xx)-4'-xxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-1-xxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
XXXXX |
|
Xxxxxxxx |
xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx X |
4-xxxxx-1-xxxxxxxxxxxxxxx-1-xxxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx X |
xxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx C |
kyselina 4-fenyl-1-methylpiperidin-4-karboxylová |
|
|
Piminodin |
ethyl-1-(3-anilinopropyl)-4-fenylpiperidin-4-karboxylát |
|
|
Piritramid |
1'-(3,3-difenyl-3-kyanpropyl-4'-ureido-1,4'-bipiperidin |
|
|
Proheptazin |
4-fenyl-1,3-dimethylazepan-4-yl-propanoát |
|
|
Properidin |
isopropyI-4-fenol-1-methylpiperidin-4-karboxylát |
|
|
Racemethorfan |
(9RS,13RS,14RS)-3-methoxy-17-methylmorfinan |
|
|
Racernoramid |
(3RS)-2,2-dyfenil-3-methyl-4-morfolino-1-(pyrrolidin-1-yl)butan-1-on |
|
|
Racemorfan |
(9RS,13RS,14RS)-17-methylmorfinan-3-ol |
|
|
Rernifentanil |
methyl-3-[4-(N-acetonylanilono)4-(methoxykarbonyl)]piperidino]propanoát |
|
|
Sufentanil |
N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid |
|
|
Tapentadol |
3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]fenol |
|
|
Thebain |
4,5α-epoxy-3,6-dimethoxy-17-triethylmorfina-6,8-dien |
|
|
Thebakon |
(5R)-4,5-epoxy-3-methoxy-17-methyImorfin-6-en-6-yl-acetát |
|
|
Thiofentanyl |
N-{1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid |
|
|
Tilidin |
ethyl-(1RS,2RS)-2-(dimethylamono)-1-fenylcyklohex-3-en-1-karboxylát |
|
|
Trimeperidin |
(RS)-4-fenyl-4-(1,2,5-trimethylpiperidin-4-yl)propanoát |
Včetně xxxxxxx omamných xxxxx xxxxxxxxx v tomto xxxxxxx, xxxx xxxxxx x xxxxxx xxxxxxxx xxxxx uvedených x xxxxx xxxxxxx a xxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx xxxxxx solí xxxxxxx, xxxxxx a xxxxx xx xxxxx xxxxxxxxx, xxx xxxx xxxx xxxxx xxxxxxxxx.
Příloha č. 2 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 2 xxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v xxxxxx xxxxxx |
Xxxxxxxx název podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxx |
|
|
Xxxxxxxxxxxxxxxx |
(1X,2X)-1-xxxxxx-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxx-xxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
4,5α-xxxxx-17-xxxxxx-3-(2-xxxxxxxxxxxxxxx)xxxxxx-7-xx-6α-xx |
|
|
Xxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx--7-xx-6-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
X-[(1XX)-1-xxxxxx-2-xxxxxxxxxxxxxxx]-X-(2-xxxxxxx)xxxxxxxxxx |
Xxxxxx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx, xxxx xxxx xxxxxxxx látek xxxxxxxxx x xxxxx xxxxxxx, xxxxxx xxxx xxxxxxx xxxxx xxxxxxxxx x xxxxx seznamu xx xxxxx případech, xxx tyto soli xxxxx existovat.
Xxxxxxx x. 3 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 3 omamných xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v českém xxxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
| Xxxxxxxxxxxxxx | X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxx | |
| Xxxxxxxxxxxxxxxx | X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxx-2-xxxxxx | |
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxx |
[5X,6X,7X,14X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx- 17-xxxxxx-6,14-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxx |
(5X,6X)-4,5-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6-xxxx-xxxxxxxx |
|
|
Xxxxxxxxxxx |
1-[4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxx-4-xx]xxxxxx-1-xx |
|
|
Xxxxxx |
X xxxxxxxx xxxxxx xxx léčebné xxxxxxx xxxxxxx x xxxxxxx x. 1 |
|
|
Pryskyřice x konopí |
Včetně solí xxxxxxxx látek xxxxxxxxx x xxxx xxxxxxx xx xxxxx případech, xxx xxxx soli xxxxx existovat.
Xxxxxxx č. 4 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 4 psychotropních xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x českém xxxxxx / xxxxxx xxxxx |
Xxxxx mezinárodní xxxxxxxxxx xxxxx xxxx xxxxx xxxxxx xxxxx |
Xxxxxxxx název xxxxx IUPAC |
Poznámka |
|
AB-CHMINACA |
N-[(1S)-1 -(aminokarbonyl)-2-methylpropyl]-1(cyklohexylmethyl)-1H-indazol-3-karboxamid |
||
|
AB-FUBINACA |
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorbenzyl)-1H-indazol-3-karboxamid |
||
|
AB-PINACA |
N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1-pentyl-1H-indazol-3-karboxamid |
||
|
4-Acetoxy-N-methyl-N-ethyltryptamin |
4-AcO-MET |
{3-[2-(ethylmethylamino)ethyl]-1H-indol-4-yl}acetát |
|
|
o-Acetylpsilocin |
4-AcO-DMT |
{3-[2-(dimethylamino)ethyl]-1H-indol-4-yl}acetát |
Psilacetin |
|
ADB-CHMINACA |
N-[1-(aminokarbonyl)-2,2-dimethylpropyl]-1-(cyklohexyl xxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XX-7921 |
3,4-xxxxxxx- N-{[1-(dimethylamino)cyklohexyl]methyl}benzamid |
||
|
AL-LAD |
(6aR,9R)-7-allyl-N,N-diethyl-6,6a,8,9-tetrahydro-4H-indol[4,3-fg]chinolin-9-karboxamid |
6-allyl-6-nor-LSD |
|
|
AM-2201 |
[1-(5-fluorpentyl)-1H-indol-3-yl](naftalen-1-yl)methanon |
||
|
AMB-FUBINACA |
FUB-AMB |
Methyl 2-({1-[(4-fluorfenyl)methyl]-1H-indazol-3-karbonyl}amino)-3-methylbutanoát |
MMB-FUBINACA |
|
AMB-CHMICA |
Methyl (2X)-2-{[1-(xxxxxxxxxxxxxxxx)xxxxx-3-xxxxxxxx]xxxxx}-3-xxxxxxxxxxxxxx |
||
|
5-Xxxxxxxxxxxxxxxx |
5-XXX |
5-(2-xxxxxxxxxxx)xxxxx |
|
|
XXXXX |
XXX-001, 2XX1 |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
|
|
XXXXXXX |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
XXX48 |
|
|
xx-XXX |
2-xxxxx-1-(4-xxxxxxxxxxxx)xxxxxx-1-xx |
||
|
Xxxxxxxxx |
xx-XXXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
XXXX |
3,4-XXXX |
2-xxxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
|
25X-XXXXx |
2-(4-xxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
Xxxxx-36 |
|
|
25X-XXXXx |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
2X-X-XXXXx |
|
|
25X-XXXX |
2-{[2-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxxxxxx]xxxxxx}xxxxx |
2X-X-XXXX; Xxxxx-27 |
|
|
25X-XXXXx |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
XXXXx-2X-X |
|
|
Xxxxx-Xxxxxxxxx |
(2X)-1-(4-xxxxxxxx[2,3-x][1]xxxxxxxxxx-8-xx)xxxxxx-2-xxxx |
||
|
Xxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxx-1-xx |
X1 |
|
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
XXX |
|
4-Xxxxx-X-xxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
4-Xxxxxxxxxxxxxxxxxx |
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxxxxxx |
4-Xx-xXX |
X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
|
|
2X-X |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xxxx |
||
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
x-XXX |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
|
2-Xxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4-Xx-α-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
XXXXX-4XX-XXXXXX |
XXX-78 |
1-(4-xxxxxxxxxx)-X-(1-xxxxxx-1-xxxxxxxxxx)xxxxxxx-3 -xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
Xxxxxxxxxxx-X; XX-X |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-7 |
[4-(xxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
XX-47,497 |
2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-5-(2-xxxxxxxxxxx-2-xx)xxxxx |
||
|
XXX-13 |
(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx |
XX-13 |
|
|
XXXX |
1,4-xxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-2-xxxxx-xxxxxxxxxxxx |
||
|
Xxxxxxxxxxxx-2-xxxxx xxxxxxxx |
X-(2-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
|
Xxxxxxxxxxxx-4-xxxxx xxxxxxxx |
X-(4-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
|
Xxxxxxxxx |
Xx-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)-1-xxxxxxx |
Xxxxxxxxxxxxx |
|
Xxxxxxxxxx |
2-xxxxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
Xx 5-3448 |
|
Xxxxxxxxxxxxxxxx |
XXX |
X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx]xxxx |
|
|
Xxxxxxxxx |
XXX; 1,2-DEP; XXXX |
1-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
XX1X4X21 |
|
5-Xxxxxxxxxxxxxxxxxxxxxxxxxxxx |
5-XXXXX; XXXX |
1-(2,3-xxxxxxxxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
x-Xxxxxx-4-xxxxxxxxxxxxxx |
4,4'-XXXX |
4-xxxxxx-5-(4-xxxxxxxxxxx)-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
x4-XXXX |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
3-(1,2-xxxxxxxxxxxxxx)-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
|
|
2,3-Xxxxxxxxxxxxxxxxxxx |
2,3-XXXX |
1-(2,3-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
2,4-Xxxxxxxxxxxxxxxxxxx |
2,4-XXXX |
1-(2,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3,4-Xxxxxxxxxxxxxxxxxxx |
3,4-XXXX |
1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxx |
XXX |
X-[2-(xxxxx-3-xx)xxxxx]- N,N-dimethylamin |
|
|
Brolamfetamin |
DOB |
(2RS)-1-(4-brom-2,5-dimethoxyfenyl)propan-2-amin |
|
|
2,5-Dimethoxy-4-chloramfetamin |
DOC |
1-(4-chlor-2,5-dimethoxyfenyl)propan-2-amin |
|
|
Dimethoxyethylamfetamin |
DOET |
(2RS)-1-(4-ethyl-2,5-dimethoxyfenyl)propan-2-amin |
|
|
Dimethoxymetamfetamin |
STP, XXX |
(2XX)-1-(2,5-xxxxxxxxx-4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2,5-Xxxxxxxxx-4-xxxxxxxxxxxx |
XXX |
1-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
5-XXXX |
1-(1-xxxxxxxxxx-5-xx)-X-xxxxxxxxxxx-2-xxxx |
||
|
6-XXXX |
1-(1-xxxxxxxxxx-6-xx)-X-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxx |
Xx-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
3,4-xxxxxxxxxxxxxxx- xxxxxxxxxxxxxx |
|
Xxxxxxxxxxxx |
Xxxxxxx |
(2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxx |
XXXXX; xx-XXXX |
1-(xxxxx[x][1,3]xxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
X-xxxxx-xxxxxxxx |
|
XXX-XXX |
(6xX,9X)-X,X-xxxxxxx-7-xxxxx-4,6,6x,7,8,9-xxxxxxxxxxxxxx-[4,3-xx]xxxxxxxx-9-xxxxxxxxxx |
||
|
Xxxxxxxx |
XXX 3219; Xxxxx |
4-(2-xxxxxxxxxx)-2-xxxxx-9-xxxxxx-6X-xxxxxx[3,2-x][ 1,2,4]triazolo[4,3-a][1,4]diazepin |
|
|
Ethylfenidát |
(RS)-ethyl-2-fenyl-2-piperidin-2-ylacetát |
||
|
2-Ethylmethkathinon |
2-EMC |
(RS)-2-methylamino-1-(2-ethylfenyl)propan-1-on |
|
|
3-Ethylmethkathinon |
3-EMC |
(RS)-2-methylamino-1-(3-ethylfenyl)propan-1-on |
|
|
4-Ethylmethkathinon |
4-EMC |
(RS)-2-methylamino-1-(4-ethylfenyl)propan-1-on |
|
|
N-ethylnorpentedron |
N-ethylpentedron |
2-(ethylamino)-1-fenyl-pentan-1-on |
a-ethylaminopentiofenon |
|
Etryptamin |
3-(2-aminobutyl)indol |
||
|
2-Fluoramfetamin |
2-FA |
1-(2-fluorfenyl)propan-2-amin |
|
|
3-Fluoramfetamin |
3-FA |
1-(3-fluorfenyl)propan-2-amin |
|
|
4-Fluoramfetamin |
4-FA |
1-(4-fluorfenyl)propan-2-amin |
|
|
5F-ADBICA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid |
||
|
5F-AKB48 |
N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-indazol-3-karboxamid |
||
|
5F-AMB-PINACA |
5F-AMB |
Methyl-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3-methylbutanoát |
5F-AMP |
|
Fentanyl xxxxxxxxx xxxxxx |
Xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]-xxxxxxxxx |
|
|
3X-Xxxxxxxxxxx |
3-XXX; XXX-593 |
2-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
|
4X-Xxxxxxxxxxx |
4-XXX |
2-(4-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
|
4-Xxxxx-xxxxxxxxxxxxx |
4X-XX |
X-(4-xxxxxxxxxxx)-X-[(1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx)]xxxxxxxxx |
|
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(2-xxxxxxxxxx)-X-[1 -(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
2-XX, x-XX |
|
3-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(3-xxxxxxxxxx)-X-[1 -(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
3-XX, x-XX |
|
4-Xxxxxxxxxxxxxxxxxxxxx |
4X-xXX |
X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
|
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
|
4-Xxxxxxxxxxxxxxxxxx |
4X-XXX; 4-FMPH |
Methyl-2-(4-fluorfenyl)-2-(2-piperidyl)acetát |
4F-TMP |
|
4-Fluorpentedron |
4-FPD; 4-F-pentedron |
1-(4-fluorfenyl)-2-(methylamino)pentan-1-on |
|
|
5F-PB-22; 5X-XXXXX |
8-xxxxxxxxxx ester kyseliny 1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxxx |
||
|
5X-XXXX-XXXXXX |
5X-XXX |
xxxxxx (S)-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát |
|
|
5FUR-144 |
[1-(5-fluorpentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyklopropyl)methanon |
XLR-11 |
|
|
Furanylfentanyl |
FU-F |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-furan-2-karboxamid |
2-furanoylfentanyl |
|
4-Hydroxy-N-methyl-N-ethyl tryptamin |
4-HO-MET |
3-{2-[ethyl(methyl)amino]ethyl}-1H-indol-4-ol |
Metocin; Xxxxxxxxxxx |
|
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxx xxxxxxxxx |
4-XX-XxXX |
3-{2-[xxxxxx(xxxxxx-2-xx)xxxxx]xxxxx}-1X-xxxxx-4-xx |
Xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
(2XX)-X-xxxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
||
|
(xxx)Xxxxxxx-X-xxxxxxxx X-xxxxxx xxxxxx |
X-(1-xxxxxxxxxxxxxxx-4-xx)-X-(4-xxxxxxxxxx)xxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxxxxxxxx |
2X-X |
(4-xxx-2,5-xxxxxxxxxxxxxxxxxxx)xxxx |
|
|
XXX-018 |
(xxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-073 |
(1-xxxxx-1X-xxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-081 |
(4-xxxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-122 |
(4-xxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-200 |
[1-(2-xxxxxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-210 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3 -xx)xxxxxxxx |
||
|
XXX-250 |
2-(2-xxxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxx-1-xx |
||
|
XXX-398 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3 -xx)xxxxxxxx |
||
|
Xxxxxxxx |
(2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
||
|
(+)-Xxxxxxxx |
XXX, XXX-25 |
(+)-8β-(3,3-xxxxxxxxxxxxxx)-6-xxxxxx-9,10-xxxxxxxxxxxxxxxx |
|
|
1x-XXX, 1X-XXX |
xxxxxxxxxxx xxxxxxxx 1-xxxxxxxxx xxxxxxxxx; (6xX,9X)- X,X-xxxxxxx-7-xxxxxx-4-xxxxxxxxx- - 6,6a,8,9-tetrahydroindol[4,3-fg]chinolin-9-karboxamid |
||
|
5-MeO-MiPT |
N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amin; 5-xxxxxxx-X-xxxxxx-X-xxxxxxxxx xxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxxxxx |
2-XxX-xxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
Xxxxxxx-XxX |
2-xxxxxxx-X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
|
2-Xxxxxxxxxxxxxxx |
2-XX |
(2XX)-1-(2-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxx |
3-XX |
(2XX)-1-(3-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxx |
4-XX |
(2XX)-1-(4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2-XXXX |
1-(xxxxxxxxxx-2-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
3-XXXX |
1-(xxxxxxxxxx-3-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
4-XXXX |
1-(xxxxxxxxxx-4-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
5-XXXX |
1-(xxxxxxxxxx-5-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
6-XXXX |
1-(xxxxxxxxxx-6-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
7-XXXX |
1-(xxxxxxxxxx-7-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
XXXX |
1-xxxxxx-4-xxxxxxxxxxxxxxx |
||
|
2-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
2-XXXX |
1-(2-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
3-XXXX |
1-(3-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
4-XXXX |
1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(3-xxxxxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxxxx |
XXX |
(2XX)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
XXXX |
5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxxxxxx |
XXX, XXXX |
(2XX)-X-xxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxx |
xx-XXXX |
2-xxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-X-xxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
XXXX-XXXXXX |
X-[[1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx]-3-xxxxxx-xxxxx, xxxxxx xxxxx |
||
|
XXXX-XXXXXXXX |
2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3,3-xxxxxxxxxxxxxxxx |
||
|
XXXXX; 3,4-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
|
2,3-Xxxxxxxxxxxxxxxxxxxxxxxxx |
2,3-XXXX |
1-(1,3-xxxxxxxxxxx-4-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3,4-Xxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
1-[3,4-(xxxxxxxxxxxxx)xxxxx]-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
XXXX |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
5-XxX-XXX |
5-xxxxxxx-x-xxxxxxxxxxxxxxx |
||
|
4-Xxxxxxxxxxxx xxxxxxxx |
4-XxX-XX |
X-(4-xxxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxx |
|
|
5-XxX-XXXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-(xxxx-2-xx-1-xx)xxxx-2-xx-1-xxxx |
||
|
3-Xxxxxxxxxxxxxxxxxx |
3-XxX-XXX |
1-[1-(3-xxxxxxxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
|
Xxxxxxxx |
3,4,5-xxxxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxx |
XXX |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
(±)-5-xxxxx-4-xxxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
|
α-Xxxxxxxxxxxxxx xxxxxxxxx xxxxxx |
XX; X-X |
2-xxxxxx-X-xxxxx-X-[1-(1-xxxxxxxxxxx-2-xx)xxxxxxxxx-4-xx]xxxxxxxxxx |
|
|
2-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
2-XXXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)-xxxxxx-1-xx |
|
|
3-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
3-XXXX |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxxx)-xxxxxx-1-xx |
|
|
4-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
4-XXXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)-xxxxxx-1-xx |
|
|
Xxxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
2-(xxxxxxxxxxx)-1-(3 -xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-[5-xxxxxxx-3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
4-XXX |
1-(4-xxxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX |
X-xxxxxx-1-(xxxxxxx-2-xx)xxxxxx-2-xxxx |
|
|
XX-45 |
1-xxxxxxxxxx-4-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
||
|
2-Xxxxxxxxxxxxxxxxxxx |
2-XXX |
(2XX)-1-[2-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxxx |
3-XXX |
(2XX)-1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxxx |
4-XXX |
(2XX)-1-[4-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxx |
4-XXX-xXx; MEX |
(3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-on |
|
|
Naftylpyrovaleron |
Nafyron |
1-(naftalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-on |
O-2482 |
|
N-methyl-2-aminoindan |
N-methyl-2AI |
2,3-dihydro-N-methyl-1H-inden-2-amin |
NM-2AI |
|
NM-2201, XXX-2201 |
xxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXxxxxxxxx |
X-3217 |
X-(2-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
|
x-Xxxxxxxxxxxxxxxxx |
XXX |
3-{-2-[(xxxxxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxxxxxxxx}xxxxx |
|
|
Xxxxxxxxx |
3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
||
|
Xxxxxxxxxxx |
XXX |
X-xxxxx-1-xxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxx |
xxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(4-xxxxxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
1-(4-xxxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
Xxxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxx |
Xxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx |
|
|
XX8, α-XXXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
|
XX9, α-POP |
1-fenyl-2-(pyrrolidin-1-yl)-1-oktan-1-on |
||
|
α-PVP |
1-fenyl-2-(pyrrolidin-1-yl)-1-pentan-1-on |
||
|
α-PVT |
2-(pyrrolidin-1-yl)-1-(thiofen-2-yl)pentan-1-on |
||
|
α-Pyrrolidinohexanofenon |
α-PHP |
1-fenyl-2-(pyrrolidin-1-yl)-1-hexan-1-on |
|
|
α-Pyrrolidinoisohexanofenon |
α-PiHP |
1-fenyl-4-methyl-2-(pyrrolidin-1-yl)-1-pentan-1-on |
|
|
Rolicyklidin |
PHP, XXXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxxx |
|
|
Xxxxxxxxxx X |
Xxxxxxxxxx X |
xxxxxx-(2XX,4xX,6xX,7X,9XX,10xXX,10xX)-9-xxxxxxx-2-(xxxxx-3-xx)-6x,10x-xxxxxxxx-4,10-xxxxxxxxxxxxxxxx-1X-xxxxx[x] xxxxxxxxxx-7-xxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
|
1-(3-Xxxxxxxxxxxxxxxxxxx)xxxxxxxxx |
XXXXX |
1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXX-X |
X-(1-xxxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxxxxxxx-2-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
X6x(10x)-, D6a(7)-, D7-, X8-, X10-, X9(11)-xxxxxxxxxxxxxxxxxxxx x xxxxxx xxxxxxxxxxxxx |
|
|
XX-XXX |
2-(xxxxxxxxxx-1-xx)-1-(5,6,7,8-xxxxxxxxxxxxxxxxxx-2-xx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(3,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx-2 |
XXX-2 |
(2XX)-1-(2,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2,4,6-Xxxxxxxxxxxxxxxxxxx |
XXX-6 |
1-(2,4,6-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
XX-144 |
(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXXX-018 |
|
|
X-47700 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
|
X-49900 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
|
X-51,754 |
2-(3,4-xxxxxxxxxxxx)-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]- X-xxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
XXX, XX |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx; fentanyl xxxxxxxxxx xxxxxx |
|
|
X-15 |
4-xxxxx-X-(1-xxxxxxxxxxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
||
|
X-18 |
4-xxxxx-X-(1-[2-(4-xxxxxxxxxx)xxxxx]-xxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
Xxxxxx xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxx, až xx výslovné výjimky, xxxxxxxxx x xxxxx xxxxxxx xx všech xxxxxxxxx, xxx xxxx xxxxxxxxxxxxx xxxxx xxxxxxxxx xxxxx zvláštního chemického xxxxxxxx x xxxx xxxxxxxxxxxxxx látek xxxxxxxxx x tomto seznamu xx xxxxx xxxxxxxxx, xxx mohou xxxxxxxxx.
Xxxxxxx č. 5 x nařízení vlády x. 463/2013 Sb.
Seznam x. 5 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v českém xxxxxx |
Xxxxx mezinárodní nechráněný xxxxx nebo obecný xxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxx |
xxxxxxxx 7-[(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-yl) amino]heptanová |
||
|
Buprenofin |
(2S)-2-[(5R,6R,7R,14S)-17-(cyklopropylmethyl)-4,5α-epoxy-3- xxxxxxx-6-xxxxxxx-6α,14-xxxxxxxxxxxxxx-7x-xx]-3,3-xxxxxxxx xxxxx-2-xx |
||
|
Xxxxxxxxxxxxxxxxxxxxx xxxx |
2X-X |
(4-xxxx-2,5-xxxxxxxxxxxxxxxxx)xxxx |
|
|
Xxxxxxxxxxxx |
(2X)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxx |
XXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxx |
7-(2-{[(2XX)-1-xxxxxxxxxxx-2-xx]xxxxx}xxxxx)-1,3-xxxxxxxx-7X- xxxxx-2,6-xxxx |
||
|
Xxxxxxxxxxx |
2-xxxxX-3-xxxxxxxxxxxxxx |
||
| Xxxxxxxxx | 1-xxxxx-2-xxxxxxxxx-xxx-2-xxxx | ||
|
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-1X-1,4-xxxxxxxxxxxxx-2(3X)-xx |
||
|
XXX |
xxxxxxxx 4-hydroxybutanová |
||
|
Levamfetamin |
(2RS)-1-fenylpropan-2-amin |
||
|
Levmetamfetamin |
(2RS)-1-fenyl-N-methylpropan-2-amin |
||
| Lisdexamfetamin | (2S)-2,6-diamino-N-[(2S)-1-fenylpropan-2-yl]hexanamid | ||
|
Meklochalon |
3-(2-chlorfenyl)-2-methyl-1,2-dihydrochinazolin-4(3H)-on |
||
|
Metachalon |
2-rnethyl-3-(2-methylfenyl)-1,2-dihydrochinazolin-4(3H)-on |
||
|
Metamfetamin |
(2S)-1-fenyl-N-methylpropan-2-amin |
||
|
Metamfetamin xxxxxxxxx |
(2XX)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxx |
xxxxxx-(2XX)-2-xxxxx-2-[(2XX)-xxxxxxxxx-2-xx]xxxxxx |
||
|
Xxxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-(1-xxxxxxxxxxx)xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
xxxxx-9-XXX |
Δ9-xxxxxxxxxxxxxxxxxxx (XXX) a xxxx xxxxxxxxxxxxx |
xxxx. (-)-xxxxx-Δ9-XXX |
|
Xxxxxxxx |
(2XX)-1-xxxxx-1-xxxxxxx-3-[4-(2-xxxxxxxxxxxxxxx)xxxxxxxxx-1-xx] xxxxxx-2xx |
Xxxxxx xxxx látek xxxxxxxxx x této xxxxxxx xx všech xxxxxxxxx, kdy existence xxxxxxxx solí xx xxxxx.
Xxxxxxx č. 6 x nařízení xxxxx x. 463/2013 Xx.
Xxxxxx x. 6 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x českém xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
xxxxxxxx 5-(1-xxxxxxxx-1-xx-1-xx)-5-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(3XX)-3-xxxxx-3-xxxxxxxxxxxxxx-2,6-xxxx |
||
|
Xxxxxx |
(+)-xxxxxxxxxxxxxxxx |
(1X,2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
|
|
Xxxxxxxxxxx |
(2X,6X,11X)-6,11-xxxxxxxx-3-(3-xxxxxxxxx-2-xx-1-xx)-1,2,3,4,5,6- hexahydro-2,6-methano-3-benzazocin-8-ol |
||
|
Pentobarbital |
kyselina 5-ethyl-5[(1RS)-1-methylbutyl]barbiturorá |
Včetně xxxx xxxxx uvedených x xxxx xxxxxxx xx všech případech, xxx xxxxxxxxx xxxxxxxx xxxx xx xxxxx.
Xxxxxxx č. 7 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 7 psychotropních xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x českém xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx obecný xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxx |
8-xxxxx-6-xxxxx-1-xxxxxx-4X.[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
2-(xxxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx |
||
|
Xxxxxxxx |
5-xxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
(+)-X-xxxxxx-X-(2-xxxxx-1-xxxxxxxxxxx)-X-xxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
1-xxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
7-xxxx-5.(2-xxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
2-xxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxxx[4,3-x]xxxxxxxx |
||
|
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2xx |
||
|
Xxxxxxxxx |
8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
Xxxxxxxxxxxxx |
1-xxxxx-3-xxxxxxxxx-1-xx-4-xx-3-xx |
||
|
Xxxxxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
xxxxx-7-xxxxx-5-(2-xxxxxxxxxx)-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3- xxxxxxxxxx |
||
| Xxxxxxxxx | 7-xxxxx-5-(2-xxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | ||
|
Xxxxxxxxxxxxx |
(2X,3X)-2-xxxxx-3,4-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-3-xxxxxxxxxxxx[2.2.1]xxxxxx |
||
|
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxx |
(±)-1-xxxxx-2-[(2-xxxxxxxxx)xxxxx]xxxxxx |
||
|
XXxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
XXxxxxxxxxx |
7-xxxxx-2-[2-(xxxxxxxxxxxx)xxxxx]-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx- 2-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-(2,2,2-xxxxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxx |
10-xxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx -6(5X)-xx |
||
|
Xxxxxxxxxxxxxxxx |
7-xxxxx-5-xxxxx-2-(xxxxxxxxxxx)-3X-1,4-xxxxxxxxxxxxx-4-xxxx |
||
|
Xxxxxxxxx |
7-xxXxx-5-xxxxx-1-xxxxxx-2-xxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-3-xx-xxxxxxxx xxxxxxxx |
||
|
Xxxxxxx |
(2XX)-2-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
11-xxxxx-12x-xxxxx-2,8-xxxxxxxx-8,12x-xxxxxxx-4X-[1,3]xxxxxxx[3,2-x][1,4] xxxxxxxxxxxx-4,7(6X)-xxxx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1X-1,5-xxxxxxxxxxxx-2,4(3X,5X]-xxxx |
||
|
Xxxxxxxxxx |
5-{2-xxxxxxxxxX}-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-2-xxx--2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-xxxxxx[2,3-x][1,4]xxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
10-xxxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4] xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxxxx |
XXX |
(-)-1-(xxxxxxxxxxxxx)-1,2-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)-2-[(4-xxxxxxxxxxxxxxx-1-xx)xxxxxx]-8-xxxxx-2,4-xxxxxxx-1X- xxxxxxxx[1,2-x][1,4]xxxxxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2 -xx |
||
|
Xxxxxxxx |
5-(4-xxxxxxxxxx)-2,5-xxxxxxx-3X-xxxxxxx[2,1-α]-xxxxxxxx-5-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
(±)-2-[(3-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
2-xxxxxx-2-xxxxxxxxxxxx-1,3-xxxx-xxxxxxxxxx |
||
|
Xxxxxxxx |
X-(xxxxxxxxxxxxxx)-3-(2-xxxxx-1-xxxxxxxxxxx)xxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxx |
5-xxxxx-5-xxxxx-1-xxxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
3,3-xxxxxxx-5-xxxxxxxxxxxxxxx-2,4-xxxx |
||
|
Xxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-xxxxxxxx[1,5-α][1,4]xxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
5-xxxxX-1-xxxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
5-xxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxx |
10-xxxxx-11x-xxxxx-2-xxxxxx-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4] xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxx |
5-xxxxX-2-xxxxx-1,3 -xxxxxxxxxx-4-xx |
||
|
Xxxxxxxxx |
7-xxxxxx-4-xxxxx-1-(xxxx-2-xx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxx |
xxxxxxX(2-xxxxxxxxx)xxxxxxxx |
||
|
Xxxxxxxx |
7-xxxxx-1-(xxxxxxxxxxxxxxxxx)-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxx |
(±)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxx |
5-xxxxx-5-(1-xxxxxxxxxxxxxxxx)xxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxx |
(XX)-7-xxxxx-5-xxxxx-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-(xxxxxxxx-1-xx-1-xx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-α][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
5-(1-xxxxxxxxxxx)-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxx |
X,X,6-xxxxxxxxx-2-(4-xxxxxxxxxxx)xxxxxxxx[1,2-α]xxxxxxx-3-xxxxxxxx |
Xxxxxx xxxx látek xxxxxxxxx x této xxxxxxx xx všech xxxxxxxxx, xxx xxxxxxxxx xxxxxxxx solí xx xxxxx.
Xxxxxxx x. 8 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 8 xxxxxxxxx xxxxxxxxx
|
Xxxxxxxxx xxxxxxxxxx: |
Xxxxxxxx: |
||
|
1) |
xxxxx x xxxxxxxx látek: acetyldihydrokodein dihydrokodein ethyImorfin folkodin kodein nikodikodin nikokodin norkodein |
Mohou xxxxxxxxx xxxxx xxxx více xxxxxxx látek (nikoliv xxxx omamných) x xxxxxxxx omamné látky |
|
|
a) |
v xxxxx xxxxxxx, tobolce, xxxxxx, xxxxx, xxxx. x jiné xxxxxx xxxxx xxxxx xxxxxxxxxx 100 xx, |
||
|
x) |
x roztoku xxxxx xxx koncentrace xxxxx xxx 2,5 % |
||
|
2) |
xxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxx nesmí xxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx xxxxxx xxxxx 0,5 xx. |
|
x) |
Xxxxxxxx atropin-sulfátu xxxx xxx xxxxxxx 5 % k xxxxxxxx xxxxxxxxxxxx x xxxxx tabletě, xxxxxx, xxxxxx, xxxxx, popř. xxxx xxxxxx xxxxx. |
||
|
3) |
xxxxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxxxx nesmí xxxxxxxxxx x jedné xxxxxxx, xxxxxxx, xxxxxx, čípku, xxxx. x xxxx xxxxxx formě 2,5 xx. |
|
x) |
Xxxxxxxx xxxxxxx-xxxxxxx xxxx xxx nejméně 1 % k množství xxxxxxxxxxxx x jedné xxxxxxx, tobolce, xxxxxx, xxxxx, popř. x xxxx xxxxxx xxxxx. |
||
|
4) |
xxxxxxxxxxxxxxxx |
Xxxxxxxx xxxxxxxxxxxxxxxxx |
|
|
x) |
xxxxx xxxxxxxxxx 135 xx x xxxxx xxxxxxx, tobolce, xxxxxx, xxxxx, příp. x xxxx xxxxxx xxxxx. |
||
|
x) |
x xxxxxxx xxxxx xxx xxxxxxxxxxx xxxxx xxx 2,5 %. |
||
|
Přípravek xxxxx xxxxxxxxx žádnou xxxxxxxxxxxx xxxxx. |
|||
|
5) |
xxxxxx |
Xxxxxxxx xxxxxxx xxxxx xxxxxxxxxx 0,1 % xxxxxxx. |
|
|
6) |
xxxxx nebo xxxxxx |
x) |
Xxxxxxxx xxxxxxx nesmí xxxxxxxxxx 0,2 %. |
|
x) |
Xxxx mohou xxxxxxxxx xxxxx xxxx xxxx xxxxxxx látek (xxxxxxx však xxxxxxxx). |
||
|
Xxxxxx xxxxx v xxxxxxxxx xxxxxxxx nesmí xxx xxxxxx získána xxxx x xxxxxxx množství, xxx xxxxxxxx veřejné xxxxxx |
|||
|
7) |
xxxxxxxxxxxxx xxxxxx x xxxxx |
x) |
Xxxxxxxx opia v xxxxxx xxxxx xxx xxxxx xxx 10 %. |
|
x) |
Xxxxxxxx ipekakuanhového xxxxxx xxxxx být xxxxx xxx 10 %. |
||
|
c} |
Množství xxxxx xxxx více xxxxxxx látek (nikoliv xxxx xxxxxxxxx) xxxxx xxx xxxxx xxx 80%. |
||
|
8) |
xxxxxxxxx |
x) |
Xxxxxxxxx xxxxxxxxx xxxxx xxxxxxxxxx 100 mg x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. v xxxx Xxxxxx formě. |
|
b) |
Mrtožství methylcelulosy x přípravku musí xxx xxxxxxx stejné xxxx xxxxx xxx xxxxxxxxx. |
||
Xxxxxx xxxxxxxxxxxx vyrobených xxxxxxxxx, xxxxxxx xxxxxx xxxxxx xx vyšší xxx X4 xxxx XX2.
Čl. XX
Xxxx nařízení xxxx xxxxxxxx v xxxxxxx xx směrnicí Xxxxxxxxxx parlamentu a Xxxx (EU) 2015/1535 xx xxx 9. xxxx 2015 o xxxxxxx xxx poskytování xxxxxxxxx x oblasti xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx společnosti.
Čl. II xxxxxx právním předpisem x. 46/2017 Xx. x účinností xx 1.3.2017
Xx. XX
Xxxx nařízení xxxx xxxxxxxx v xxxxxxx xx směrnicí Xxxxxxxxxx parlamentu a Xxxx (EU) 2015/1535 xx dne 9. xxxx 2015 x xxxxxxx xxx poskytování xxxxxxxxx v xxxxxxx xxxxxxxxxxx předpisů x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. XX xxxxxx xxxxxxx předpisem x. 30/2018 Xx. x xxxxxxxxx xx 8.3.2018
Xx. XX
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 xx xxx 9. xxxx 2015 o xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx v oblasti xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx společnosti.
Čl. XX xxxxxx xxxxxxx xxxxxxxxx x. 242/2018 Sb. x xxxxxxxxx xx 25.10.2018
Právní předpis x. 463/2013 Xx. xxxxx xxxxxxxxx xxxx 1.1.2014.
Xx xxxxx xxxxxx xxxxxxxx xxxxxxxx xxxx xxxxxxxxxx xxxxx a xxxxxxxx xxxxxxxxxxx právním předpisem x.:
243/2015 Sb., kterým xx xxxx nařízení xxxxx x. 463/2013 Xx., x seznamech xxxxxxxxxx látek
s xxxxxxxxx xx 1.10.2015
46/2017 Sb., xxxxxx xx mění xxxxxxxx xxxxx x. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx xxxxx, xx znění xxxxxxxx xxxxx x. 243/2015 Xx.
x xxxxxxxxx od 1.3.2017 s xxxxxxxx xxxxxxxxx xxxxxxxxxx, která xxxxxxxx xxxxxxxxx 1.5.2017
30/2018 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx xxxxx, xx znění xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 8.3.2018
242/2018 Sb., xxxxxx xx xxxx xxxxxxxx vlády x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx znění xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 25.10.2018
184/2021 Xx., xxxxxx xx xxxx nařízení xxxxx č. 463/2013 Xx., o seznamech xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx předpisů
s xxxxxxxxx xx 3.6.2021
159/2022 Xx., kterým se xxxx nařízení xxxxx x. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx xxxxx, xx znění xxxxxxxxxx předpisů
s xxxxxxxxx xx 1.7.2022
228/2023 Xx., xxxxxx xx mění xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx látek, xx xxxxx pozdějších xxxxxxxx
x xxxxxxxxx xx 1.8.2023
52/2024 Sb., kterým xx mění xxxxxxxx xxxxx x. 463/2013 Xx., x seznamech xxxxxxxxxx xxxxx, ve xxxxx xxxxxxxxxx předpisů
s xxxxxxxxx xx 6.3.2024 x 1.1.2025
176/2023 Sb., xxxxxx xx xxxx xxxxxxxx xxxxx č. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx pozdějších xxxxxxxx
x účinností xx 1.7.2024 x 1.1.2025
419/2024 Xx., xxxxxx se xxxx xxxxxxxx vlády x. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx xxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.1.2025 x 1.4.2025
534/2025 Sb., kterým xx xxxx xxxxxxxx vlády x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx předpisů, x xxxxxxxx xxxxx x. 11/2025 Sb., x xxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxx
x účinností xx 16.12.2025 s xxxxxxxx xxxxxxx x. 5, xxxxx xxxxxx účinnosti 1.1.2026
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx v xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx právního xxxxxxxx.
1) Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx, xxxxxxxxx pod č. 47/1965 Sb., xx xxxxx Xxxxxxxxx x změnách Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx, vyhlášeného pod č. 458/1991 Sb.
2) Xxxxxx x xxxxxxxxxxxxxx xxxxxxx, xxxxxxxxx xxx č. 62/1989 Sb.
3) Xxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX xx xxx 25. xxxxx 2004, xxxxxx xx xxxxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxx xx znaků xxxxxxxxxx xxxxxxx trestných xxxx x xxxxxx x xxxxxxx nedovoleného xxxxxxx x xxxxxxx.
Xxxxxxxx Xxxxxxxxxx parlamentu x Xxxx (XX) 2017/2103 xx dne 15. xxxxxxxxx 2017, xxxxxx xx xxxx rámcové xxxxxxxxxx Xxxx 2004/757/SVV x xxxxx zahrnout xx xxxxxxxx xxxxx xxxx xxxxxxxxxxxxx látky x xxxxxxx rozhodnutí Xxxx 2005/387/SVV.